StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ADVLIFE.BO$31.99+0.00%
Fair $31.99+0.0%

ADVLIFE.BO

Advance Lifestyles Limited

Consumer Cyclical / Textile ManufacturingBSE

$31.99

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $31.99Fund rank 23/100 · Data gapFallback financials|
SA 35/D
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-3.2M · quality 43.0/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 31/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

35/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · ADVLIFE.BOLocal privado en este navegador · Advance Lifestyles Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$199M

P/E

29.1x

↑

EV/EBITDA

14.9x

↑

ROE

5.1%

↑

Gross Margin

N/A

•

Debt/Equity

1.53

↑
52-Week Range$32
$20$34

TradingView lightweight chart

ADVLIFE.BO price, volumen y niveles de valoración

Último $31.99Periodo +28.0%
Fair value: $31.99

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

—

FCF CAGR

—

FCF margin

—

FCF / Net income

-0.22x

Latest source

Provider fallback

Margin decomposition

Último año: revenue — · net income $14.3M · FCF $-3.2M

2022-FY → 2025-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

—— pts

FCF margin

—— pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue———$23.1M—
Net Income$14.3M$14.3M$2.1M$5.4M$9.4M
EBITDA$42.1M$42.1M$27.5M$28.3M$-4.9M
EPS2.292.290.340.861.51
Gross Margin———0.1%—
Operating Margin———-16.1%—
Net Margin———23.2%—
Balance Sheet
Debt/Equity1.531.531.531.431.41
Cash Flow
Free Cash Flow$-3.2M$-3.2M$-8.0M$115000.00$3.3M
Returns
ROE5.1%5.1%0.8%2.0%3.1%
Valuation
P/E29.0829.08131.7136.4510.23
EV/EBITDA14.8914.8924.7520.10—
P/B0.720.721.060.750.31
Growth & Yield
EPS Growth573.5%573.5%-60.5%-43.2%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

7.4%

razonable

EPS terminal req.

$2.84

Spread vs growth

566.1%

5Y implied EPS CAGR

8.4%

razonable

EPS terminal req.

$3.43

Spread vs growth

565.1%

10Y implied EPS CAGR

9.2%

razonable

EPS terminal req.

$5.53

Spread vs growth

564.3%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +7.4%

Total return

+7.4%

Start / end P/E

87.6x → 14.0x

EPS bridge

0.34 → 2.29

Residual

-482.1%

EPS growth+573.5%
Multiple rerating-84.1%
Dividend+0.0%
Residual / FX / buybacks / cross-term-482.1%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.